EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

hapE and hmg1 Mutations Are Drivers of cyp51A -Independent Pan-Triazole Resistance in an Aspergillus fumigatus Clinical Isolate

Ana C O Souza, Wenbo Ge, Nathan P Wiederhold, Jeffrey M Rybak, Jarrod R Fortwendel, P David Rogers iD

Microbiology Spectrum · 2023

DOI: 10.1128/spectrum.05188-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Ana C O Souza und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Aspergillus fumigatus, Aspergillosis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triazole resistance is an important cause of treatment failure and high mortality rates for A. fumigatus human infections. Although Cyp51A-associated mutations are frequently identified as the cause of A. fumigatus triazole resistance, they do not explain the resistance phenotypes for several isolates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aspergillus fumigatusAspergillosisHumansTriazolesFungal ProteinsDrug Resistance, FungalAntifungal AgentsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Aspergillus fumigatusCCAAT box binding complexhapEhmg1triazole drug resistance

Substanzen

TriazolesFungal ProteinsAntifungal Agents

Autor:innen und Institutionen

  • Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Department of Clinical Pharmacy and Translational Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Fungus Testing Laboratory, Department of Pathology and Laboratory Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.

ORCID-Profile: P David Rogers

Förderung

  • NIAID NIH HHS
  • HHS | National Institutes of Health

Zitieren

APA

Souza, A. C. O., Ge, W., Wiederhold, N. P., Rybak, J. M., Fortwendel, J. R., & Rogers, P. D. (2023). hapE and hmg1 Mutations Are Drivers of cyp51A -Independent Pan-Triazole Resistance in an Aspergillus fumigatus Clinical Isolate. Microbiology Spectrum. https://doi.org/10.1128/spectrum.05188-22

Vancouver

Souza ACO, Ge W, Wiederhold NP, Rybak JM, Fortwendel JR, Rogers PD. hapE and hmg1 Mutations Are Drivers of cyp51A -Independent Pan-Triazole Resistance in an Aspergillus fumigatus Clinical Isolate. Microbiology Spectrum. 2023. doi:10.1128/spectrum.05188-22

BibTeX
@article{Souza2023,
  author = {Souza, Ana C O and Ge, Wenbo and Wiederhold, Nathan P and Rybak, Jeffrey M and Fortwendel, Jarrod R and Rogers, P David},
  title = {hapE and hmg1 Mutations Are Drivers of cyp51A -Independent Pan-Triazole Resistance in an Aspergillus fumigatus Clinical Isolate},
  journal = {Microbiology Spectrum},
  year = {2023},
  doi = {10.1128/spectrum.05188-22}
}
Kostenlos starten →